Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Victory RS Science and Technology Fund is an actively managed mutual fund overseen by the RS Investments Growth Team, a franchise of Victory Capital Management. The fund seeks long-term capital growth by investing at least 80% of its assets in innovative science and technology-oriented companies across all market capitalizations. While it maintains a heavy focus on the technology sector, it also has significant exposure to the healthcare and biotechnology industries, targeting companies that drive market share through scientific innovation. The fund utilizes a research-intensive, fundamental analysis approach to identify disruptive businesses with sustainable earnings growth potential, including clinical-stage biotech firms and medical technology innovators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Victory RS Science.